20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Letter of response to Greenhawt et al. ‘LEAPing Through the Looking Glass: Secondary Analysis of the Effect of Skin Test Size and Age of Introduction on Peanut Tolerance after Early Peanut Introduction’

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references2

          • Record: found
          • Abstract: found
          • Article: not found

          Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel.

          Food allergy is an important public health problem because it affects children and adults, can be severe and even life-threatening, and may be increasing in prevalence. Beginning in 2008, the National Institute of Allergy and Infectious Diseases, working with other organizations and advocacy groups, led the development of the first clinical guidelines for the diagnosis and management of food allergy. A recent landmark clinical trial and other emerging data suggest that peanut allergy can be prevented through introduction of peanut-containing foods beginning in infancy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            LEAPing through the looking glass: secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introduction

            Background In the Learning Early About Peanut Allergy (LEAP) study, early peanut introduction in high-risk 4-11 month olds was associated with a significantly decreased risk of developing peanut allergy. However, the influences of key baseline high-risk factors on peanut tolerance are poorly understood. Methods Secondary analysis was conducted on the publically available LEAP dataset, exploring relationships between peanut tolerance, baseline peanut/egg sensitization, eczema severity/duration, age of introduction, gender, and race. Results A multiple logistic regression model predicting odds of successful oral food challenge (OFC) at 60 months noted higher odds with early introduction (OR 9.2, P<0.001, 95%CI 4.2-20.3), white race (OR 2.1, p=0.04, 95%CI 1.1-3.9), and advancing age (OR 4.8, P=0.04, 95%CI 1.1-20.8). Odds of peanut tolerance were lower with increasing peanut wheal size (OR 0.58, P<0.001, 95%CI 0.46-0.74), increased baseline SCORAD score (OR 0.98, p=0.04, 95%CI 0.97-1), and increased kU A /L of egg serum IgE (sIgE) (OR 0.99, p=0.04, 95%CI 0.98-1). The probability of peanut tolerance in the early introduction group was 83% vs. 43% in the avoidance group with SPT wheal of less than 4mm. The probability of a successful OFC was significantly higher with peanut introduction between 6-11 months than at 4-6 months. Increasing eczema severity had limited impact on the probability of peanut tolerance in the early introduction arm. Conclusion Increasing peanut wheal size predicted peanut tolerance only in the avoidance arm. Peanut introduction between 6-11 months of age was associated with the highest rates of peanut tolerance, questioning the “urgency” of introduction before 6 months.
              Bookmark

              Author and article information

              Journal
              Allergy
              Allergy
              Wiley
              01054538
              August 2017
              August 2017
              July 10 2017
              : 72
              : 8
              : 1267-1271
              Affiliations
              [1 ]Rho Federal Systems Division; Chapel Hill NC USA
              [2 ]Immune Tolerance Network; Benaroya Research Institute; Seattle WA USA
              [3 ]National Institute of Allergy and Infectious Diseases; Bethesda MD USA
              [4 ]Division of Asthma, Allergy and Lung Biology; Department of Paediatric Allergy; King's College London and Guy's and St. Thomas’ NHS Foundation Trust; London UK
              [5 ]Pediatric Allergy/Immunology; Johns Hopkins School of Medicine; Baltimore, Maryland USA
              [6 ]Department of Pediatrics; Section of Allergy and Immunology; Children's Hospital Colorado; University of Colorado School of Medicine; Aurora CO USA
              [7 ]Division of Allergy and Immunology; Department of Pediatrics; British Columbia Children's Hospital; University of British Columbia; Vancouver BC Canada
              [8 ]Division of Allergy and Immunology; Cincinnati Children's Hospital Medical Center; Cincinnati OH USA
              [9 ]Department of Pediatrics; Section of Allergy and Immunology; Nationwide Children's Hospital and The Ohio State University College of Medicine; Columbus, Ohio United States
              [10 ]Department of Pediatrics; Ann and Robert H. Lurie Children's Hospital of Chicago; Northwestern Medicine; Chicago IL USA
              [11 ]Division of Allergy-Immunology; Department of Pediatrics; The Children's Hospital of Philadelphia; Perelman School of Medicine at University of Pennsylvania; Philadelphia PA USA
              Article
              10.1111/all.13127
              5796413
              28691223
              24b78cb1-43b6-42ea-81af-0b1d134ea733
              © 2017

              http://doi.wiley.com/10.1002/tdm_license_1.1

              http://onlinelibrary.wiley.com/termsAndConditions#vor

              History

              Comments

              Comment on this article